Noise sources including thermal fluctuations and nonspecific binding can lead to lasing wavelength value (LWV) shifts which are indistinguishable from the signals generated by an actual binding event.
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Section 1. Thermal Noise and Nonspecific Binding
Noise sources including thermal fluctuations and nonspecific binding can lead to lasing wavelength value (LWV) shifts which are indistinguishable from the signals generated by an actual binding event.
Among these noise sources, thermal noise is the main limiting factor on the external cavity laser (ECL) biosensor's resolution performance when the reference sensor is not used in conjunction with the active sensor.
Temperature fluctuations have two main effects on the sensor system: (1) shift the gain profile of the semiconductor optical amplifier (SOA), and (2) modulate the dimensions and the refractive index of the photonic crystal (PC) materials. The gain profile of the SOA is extremely sensitive to temperature changes.
We observed LWV shifts with a fluctuation range of 15 pm even with a commercial SOA temperature control unit with temperature stability of 0.1°C. This large thermal noise makes it necessary to have a reference sensor that shares the same SOA to experience the same wavelength shifts caused by SOA temperature fluctuations. The PC materials used in this work and the test samples are also sensitive to ambient temperature fluctuations due to thermal expansion/contraction (characterized by coefficient of S2 thermal expansion) and thermal-opto effects (characterized by thermal-optic coefficient). We have used rigorous coupled-wave analysis computer simulations to study the effect of a small sensor temperature change on the peak wavelength of the PC. For example, a temperature change of 0.05°C results in a LWV shift of 0.1 pm due to the thermal-opto effect 1 of the TiO2 coating, and could result in a LWV shift of 9.0 pm due to the thermal expansion of UVCP. It's critical to compensate the thermal noise experienced by the PC via an identical reference sensor that is in close proximity to the active sensor and shares the same thermal environment.
In the reference well, no protein is functionalized on the surface. Thus the LWV recorded for that well reflects both thermal noise and nonspecific binding of small molecules on the GA-functionalized surface. By subtracting the LWV of the reference well from that of the active well, part of the nonspecific binding to GA surface can be compensated. Also, from Table 1 , noninteracting protein-small molecule interaction results in LWV shifts in the range of -2.4-2.6 pm which are all within 3σ ( Figure S2 ) of the noise generated when only buffer solution was added to the sensor and reference wells.
Section 2. Path to High Throughput
As an initial demonstration of the technology's capabilities, in the screen with CA II, we performed the tests in serial with the throughput of 3 tests per hour. However, throughput was increased through demonstration of screening 6 compounds at a time within a single well ( Figure 3 ), effectively resulting in a screening throughput of 18 compounds/hour.
It is our intention, with this initial demonstration of the technology, to demonstrate the capability for high throughput, which can be achieved by simple engineering of the instrument and test method. For example, our approach is based on the fact that, in an initial screening to identify small molecule binders to target proteins, we need the LWVs at the initial time point and at the end point to obtain the LWV shifts, rather than LWVs in the whole binding process. Thus, we are able to take initial LWV readings from each well in a microplate to determine the pre-binding wavelength before introduction of small molecules.
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After introduction of small molecules, a second scan of the microplate can be used to gather final LWVs for the wells. As each LWV measurement only takes <0.1 seconds, the rate of measurement is limited by the rate of the motion stage that moves the microplate over the optical detection head. Using our current system with a single optical fiber detection head, we estimate that an entire 384-well plate can be scanned in ~3 minutes. Including time for stabilization of the binding interaction, a 384-well plate, screening with 10 compounds/well, with one reference sensor for each active sensor, could screen 1,920 compounds in 15 minutes.
Besides utilizing the end-point reading method, the throughput may be further increased by using multiple SOA in parallel to perform multiple tests at the same time. Although the cost of each SOA is ~$5000, the costs of implementation of an 8-channel detection instrument is consistent with the costs of current HTS instruments.
Section 3. Materials and Methods
Materials
All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. Biosensor plates were a gift from SRU Biosystems (Woburn, MA).
Sensors and Detection Instrument
The sensor surface is a one-dimensional photonic crystal (PC). The fabrication process of PC biosensors using nanoreplica molding has been described in previous published work 2 and is briefly introduced below. An 8-inch silicon wafer with grating structure etched permanently into its surface is used as the master wafer, and the structure is replicated onto a thin layer of UV curable epoxy on a Figure S1 shows the dual-mode lasing spectrum of the ECL system, with one well immersed in DI water, and the other well immersed in 10% DMSO solution.
Overexpression and purification of GST-XIAP
The cDNA encoding human X-linked inhibitor of apoptotic protein (XIAP) was provided by Dr. in the small molecule detection assay. Since the nonspecific binding observed was very low even without a blocking step, this step was eliminated for the sake of simplifying the assay protocol.
Biotin and SA binding assay S6 Biotin dissolved in 1X PBS was added to both the control and sensing wells at a final concentration of 75 µg/mL. Biotin was allowed to incubate with SA and the sensor plate was read for 20 min at RT.
Protein−small molecule binding assays
The cognate small molecules of interest: dorzolamide, warfarin, SM-122, SM-164 (gift from Prof.
Shaomeng Wang, U. Michigan), NHI-1, 1b and 1g (gift from Prof. Filippo Minutolo, U. Pisa) and Q-VD-O-Ph (EMD Millipore) were dissolved in DMSO. Dicoumarol (gift from Prof. David Boothman, UTSW) was dissolved in basic water. The small molecules were added at a final concentration of 50 µM in 5% DMSO (1% DMSO for warfarin) into both the active and reference wells for all of the binding assays.
The sensor plate was read for 5-20 min at RT.
Dose response binding assays
Dorzolamide dissolved in 5% DMSO in 1X PBS was added to both the active and reference wells at 
High-throughput screen
A collection of 48 compounds from an in-house library in 10 mM DMSO was used for the screen, with dorzolamide a known inhibitor of CAII spiked in. The compounds were added to both the active and reference wells and screened at a final concentration of 50 µM in 5% DMSO in 1X PBS. Acetazolamide at a final concentration of 50 µM in 5% DMSO in 1X PBS was used as the positive control. 5% DMSO in 1X PBS was used as the negative control. The sensor plate with CAII immobilized on the active wells was read for 20 min at RT to obtain the binding data.
Specific binding assay for HSA and warfarin
A 1% DMSO solution in 1X PBS containing 5 structurally unrelated small molecules in addition to warfarin was added to both sensing well with immobilized HSA and control well at a final concentration S7 of 25 µM. To eliminate the possibility of nonspecific binding, the 5 other small molecules were added separately to both the sensing and control wells. The sensor plate was read for 5-10 min at RT.
Data analysis:
The Z' factor was calculated to determine the quality of the screening assay, with σ the standard deviation, and µ the mean, of positive and negative controls. Summary of the refractive index sensitivities and figure of merit (FOM) values of a variety of optical biosensor technologies. As a widely adopted metric for the intrinsic resolving power of optical biosensors, FOM incorporates the detection sensitivity S (nm• RIU -1 ) and the resonant quality factor Q and is defined as FOM= S×Q. The prism coupled SPR biosensor within the Biacore instrument has a FOM value of 2.6 × 10 4 , 5 while an ECL laser has a value of 5.9 × 10 9 , 3 indicating that the ECL biosensor has intrinsically better ability to resolve small changes in surface-adsorbed refractive index changes than SPR.
